Israeli method dramatically reduces waiting time for lab results of cancer cell detection tests following surgery to remove a malignant tumor in the abdomen.
Israeli company specializing in driverless car technology is developing new system to enable mass screening for detection of COVID-19 symptoms by using cameras and artificial intelligence.
The startup’s varied target markets are industries such as homeland security, transportation, law enforcement and banking. Now, with Covid-19, it has added value .
Mentored by engineers from the Technion, Israel’s leading technology university, a high school robotics team in Haifa produced a robot to deliver equipment, medicine and food and help protect hospital medical staff from COVID-19. By Yakir Benzion, United With Israel The robotics club at a Haifa high school has teamed up with engineers at the... Read more »
'The efficient eradication of malignant cells in human pancreas cancer xenografts presented a new model of pancreas cancer treatment,' the research team says.
'In the US alone, there are 900,000 deaths per year from organ impairment, while only 31,000 transplants are performed each year,' according to Collplant.
Vein transplantation has been done before – but only from a corpse. The donation from a living person at an Israeli hospital was the first of its kind.
The glasses provide riders with real-time data such as heart rate, speed, distance and a built-in GPS system, and come equipped with Bluetooth speakers.